Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2008
08/28/2008US20080207570 Clobetasol 17-propionate, desonide, or betamethaone valerate; emollient, wax, or fatty alcohol; nonionic surfactant; propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol, ethoxydiglycol, urea, acetone, or oleic acid propenetrating agent; nongreasy; psoriasis, skin disorders
08/28/2008US20080207561 A modified chitosan and a prostaglandin, prostamide, non-steroidal anti-inflammatory drug, or a corticosteroid; opthalmic drug delivery solution; improved bioavailability
08/28/2008US20080207560 Blending a phospholipid and a mono- or oligo-glycol ether, together with at least one bioactive component selected from the group consisting of hyaluronic acid and derivatives, vitamin A and derivatives, vitamin C and derivatives, xanthine derivatives, and ubiquinones; improved bioavailability
08/28/2008US20080207545 Using antisense oligonucleotides, small interfering RNA, and ribozymes to inhibit expression of the human steroid 5 alpha-reductase gene and thereby inhibit formation of dihydrotestosterone: skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia
08/28/2008US20080207537 Reducing agent and oxidizing agent are separately disposed and sequentially administered to a nail; oxidizer increases permeability; thioglycolic acid derivative and hydrogen peroxide; psoriasis; fungicides
08/28/2008US20080207535 Polytetrafluoroethylene (PTFE), polyoxyethylene glycol (PEG), maleic anhydride (MA), and penicillin (ampicillin or gentamicin) are reacted to yield penicillin-PEG-MA-PTFE, which inhibits Grampositive bacteria
08/28/2008US20080207516 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
08/28/2008US20080206369 Nutritional supplement preparation with piperine
08/28/2008US20080206346 Preparation of powder agglomerates
08/28/2008US20080206340 Galactomannans and/or Glucomannans For Increasing the Bioavailability of Active Substances
08/28/2008US20080206312 Therapeutic Morpholino-Substituted Compounds
08/28/2008US20080206305 drug delivery device: a base surgical mesh structure; an anchoring support element configured to receive an anchoring mechanism; and a barrier layer of cured cross-linked gel derived from fatty acid, fish oil; exhibit antiinflammatory properties, no adhesion, healing
08/28/2008US20080206304 Medical devices having polymeric regions based on styrene-isobutylene copolymers
08/28/2008US20080206303 Prolonged Release Formulations Comprising Anastrozole
08/28/2008US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules
08/28/2008US20080206247 Glycoprotein VI fusion proteins
08/28/2008US20080206223 Treatment of pompe's disease
08/28/2008US20080206222 Fullerenes; clathrates; side effect reduction
08/28/2008US20080206192 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody (Alemtuzumab)
08/28/2008US20080206184 water soluble polymer conjugated to a drug; polymer is eliminated from the body without unwanted accumulation, as measured by formation of kidney vacuoles; PEG block polymers linked by labile hydrolytically or proteolytically degraded groups (amides); leptin, tumor necrosis factor receptor, L1-7 peptide
08/28/2008US20080206182 biocompatible hydroxyalkyl starch, dextran or polyethylene glycol polymers functionalized by an aminooxy group; improved circulatory life time in vivo; reduced antigenicity and immunogenicity of the proteins; therapeutic proteins such as EPO, G-CSF, Factor VII, Factor IX, IFN beta, AT III, A1AT, Factor V
08/28/2008US20080206177 Cosmetic composition comprising at least one cationic polyurethane and at least one polyethylene glycol ester, to be applied during hair dressing
08/28/2008US20080206159 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions
08/28/2008US20080206153 Copolymer made using a molecular weight regulator having at least three functional regulating groups, such as trimethylolpropane tris(2-mercaptopropionate) (TMPTMP); e.g. TMPTMP modified ethyl acrylate-methacrylic acid-tert-butyl acrylate terpolymer; hair sprays; film forming, low viscosity formulations
08/28/2008CA2683383A1 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
08/28/2008CA2679199A1 Bispecific fusion protein having therapeutic and diagnostic potential
08/28/2008CA2678706A1 Composition for combating epistaxis
08/28/2008CA2678677A1 Delta 9 - tetrahydrocannabinol processing
08/28/2008CA2677854A1 Composition for treating xerostomia or dry mouth
08/28/2008CA2677436A1 Composition for treatment of cartilage disease
08/28/2008CA2675622A1 Hgf preparation
08/28/2008CA2623560A1 A process for preparing stable amorphous benzimidazole composition
08/27/2008EP1962094A1 Detecting agent and therapeutic agent for highly malignant breast cancer
08/27/2008EP1961425A2 Methods and compositions for the prevention and treatment of anemia
08/27/2008EP1961424A1 Activation of peptide prodrugs by HK2
08/27/2008EP1961422A1 Easily absorbed oral preparation containing xanthine derivative
08/27/2008EP1961419A1 Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor
08/27/2008EP1961417A1 Bisoprolol-containing adhesive patch
08/27/2008EP1961415A1 Adhesive preparation
08/27/2008EP1961414A1 A controlled release composition comprising a recombinant gelatin
08/27/2008EP1961413A1 Rapidly disintegratable oral tablet
08/27/2008EP1961412A1 Self-microemulsifying drug delivery systems
08/27/2008EP1961411A1 A controlled release composition
08/27/2008EP1960790A1 Annexin derivatives suitable for pretargeting in therapy and diagnosis
08/27/2008EP1959998A1 Copolymers based on polyalkylene oxide-modified n-vinyl lactam copolymers
08/27/2008EP1959993A2 Multivalent immunoglobulin-based bioactive assemblies
08/27/2008EP1959971A2 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers
08/27/2008EP1959953A2 Stabilized pharmaceutical composition of pramipexole and method of preparation thereof
08/27/2008EP1959927A1 Composition in the form of a spray containing a corticoid and an oil phase
08/27/2008EP1959926A1 Formulation comprising a drug of low water solubility and method of use thereof
08/27/2008EP1959761A1 High-potency sweetener composition with antioxidant and compositions sweetened therewith
08/27/2008EP1850877B1 Process for the preparation of alkoxyamine functionalised polyethylene glycols
08/27/2008EP1748796A4 Multilayered nanomedicine delivery system and method
08/27/2008EP1709066B1 Inclusion complexes of perindopril
08/27/2008EP1531814B1 Sustained-release tablet composition of pramipexole
08/27/2008EP1455764B1 Medicinal aerosol compositions with an amide and/or ester containing excipient compound
08/27/2008EP1450804B1 Pharmaceutical formulations comprising an immune response modifier
08/27/2008EP1446504B1 Emulsion compositions
08/27/2008EP1337262B1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
08/27/2008EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease
08/27/2008EP1015039B1 Oxygen delivery agents and uses for the same
08/27/2008CN101253192A Antitumor agent
08/27/2008CN101252932A Trazodone composition for once a day administration
08/27/2008CN101252923A Adhesive skin patch
08/27/2008CN101252914A Stable nanoparticle formulations
08/27/2008CN101252910A Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
08/27/2008CN101252909A Prolonged release formulations comprising anastrozole
08/27/2008CN101250764A Nanometer medicine-loading orlon fibre, preparation and application
08/27/2008CN101250763A Long-acting medicine-loading orlon fibre capable of degrading partly, preparation and application thereof
08/27/2008CN101250288A Cyclovirobuxine D cyclodextrin or cyclodextrin derivative clathrate compound and preparation method thereof
08/27/2008CN101250235A Full biodegradable amphipathic polysaccharides grafts as well as preparation method and use thereof
08/27/2008CN101249284A Biological medical nano hollow ellipsoid and preparation method and application thereof
08/27/2008CN101249278A Bone induction material and preparation method and application thereof
08/27/2008CN101249269A Integrin targeted imaging agents
08/27/2008CN101249266A Nano liver target direction amphipathic nature block copolymers drug administration system and preparation
08/27/2008CN101249262A Targeted nano granule of humanization monoclonal antibody trastuzumab modified packaged toxin protein, and preparation and applications thereof
08/27/2008CN101249261A Kidney syndrome hemorrhagic fever mucosa immune vaccines and method of preparing the same
08/27/2008CN101249248A Hepatitis B medicament and method of preparing the same
08/27/2008CN101249224A Method for improving vitamin C Yinqiao tablet stability
08/27/2008CN101249170A Preparation of houttuynia cordata freeze-dried powder needle for injections
08/27/2008CN101249159A Quick acting preparations preparation for preventing and treating chronic emphraxis pulmonary disease
08/27/2008CN101249158A Traditional Chinese medicine preparation for preventing and treating cardiovascular and cerebrovascular diseases and preparation
08/27/2008CN101249154A Nourishing blood soothe the nerves oral liquid
08/27/2008CN101249141A Asiatic moonseed extract, preparations, preparing method and use thereof
08/27/2008CN101249131A Gynostemma pentaphylla soft capsules preparations and method of preparing the same
08/27/2008CN101249130A Medicinal or health care combination for stop smoking or alleviating stop smoking syndrome
08/27/2008CN101249127A Chinese medicinal composition for curing avian coccidiosis and method of preparing the same
08/27/2008CN101249119A Compound compound paracetamol and zincgluconate dispersible tablet and method of preparing the same
08/27/2008CN101249109A Lactobacillus reuteri hollow micro-capsule and its preparing method
08/27/2008CN101249107A Medicament for curing extremity tinea and psoriasis
08/27/2008CN101249104A Traditional Chinese medicine preparation for eliminating scar
08/27/2008CN101249099A Compound gossypol acetate administer orally formulation
08/27/2008CN101249098A Polygonatum polysaccharide effervescence tablet
08/27/2008CN101249095A Preparation of emulsifiable paste for containing decoloring agent, tretinoin and skinniness steroids
08/27/2008CN101249085A Bilobalide A, B compound injection and preparation method and application thereof
08/27/2008CN101249082A Preparation of acidum citricum tamoxifen polylactic acid-glycolic co-polymer microballoons
08/27/2008CN101249081A Administer orally controlled release drug administration pharmaceutical tablet
08/27/2008CN101249080A Acetylkitasamycin dispersible tablet and method of preparing the same
08/27/2008CN101249079A Andrographolide succinic acid half-ester natrium potassium salt and preparations
08/27/2008CN101249078A Sodium rebeprazole freeze-dried injection
1 ... 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 ... 1712